Back to search

Article

Marker genes for predicting cytokine release syndrome in vitro before CAR T cell infusion

2025-05-29

Abstract excerpt

Cytokine release syndrome (CRS) and neurotoxicity are common adverse events of the Chimeric antigen receptor (CAR) T cell therapy. Assessing the cytotoxicity associated biomarkers would be essential for therapy design to avoid developing severe toxicities. In this study, we re-analyzed previously published RNAseq results of CAR T cells before infusion and combined it with the clinical response post infusion. We ob...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f75d4761-6f44-58f8-bac8-c1f6f95ddfd8
DOI
10.1101/2025.05.26.655341
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Marker genes for predicting cytokine release syndrome in vitro before CAR T cell infusionDOI 10.1101/2025.05.26.655341
Select a neighboring publication to make it the new centre.